Evidence map›Paper›PMID 35873562›Full record

ArticleFrontiers in pharmacology2022

Association Between Serum Carnosinase Concentration and Activity and Renal Function Impairment in a Type-2 Diabetes Cohort.

Jiedong Qiu, Benito A Yard, Bernhard K Krämer, Harry van Goor, Peter van Dijk, Aimo Kannt

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Histidine-Containing Dipeptides in Obesity and Cardiometabolic Health: A Systematic Scoping Review.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Article
  3. Article
  4. Review
  5. Antioxidants (Basel, Switzerland) · 2023
    Article
  6. The therapeutic potential of carnosine: Focus on cellular and molecular mechanisms.Current research in pharmacology and drug discovery · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Jiedong Qiu5th Medical Department, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
Benito A Yard5th Medical Department, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
Bernhard K Krämer5th Medical Department, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
Harry van GoorDepartment of Pathology and Medical Biology, University Medical Centre Groningen and University of Groningen, Groningen, Netherlands.
Peter van DijkDepartment of Endocrinology, University Medical Centre Groningen and University of Groningen, Groningen, Netherlands.
Aimo KanntFraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt, Germany.
University Hospital Heidelberg · DEHeidelberg University · DEIsala · NLUniversity Medical Center Groningen · NLUniversity Medical Centre Mannheim · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

carnosinasecarnosinediabetic complicationsdiabetic nephropathyhistidine-dipeptidase

Identifiers

PMID35873562
PMCPMC9304884
OpenAlexW4284898095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.